Article
Breakingviews - Pharma delivers, for others
Rating:
0.0
Views:
12
Likes:
1
Library:
1
Regeneron Pharmaceuticals and Sanofi have shown their blockbuster asthma and eczema drug, Dupixent, works unexpectedly well against chronic obstructive pulmonary disease (COPD). The progressive lung disease, which commonly crops up in heavy smokers, is the third biggest cause of death globally. A 30% reduction in exacerbations and significant lung function improvement means the drug should spin more profit. But like new and effective obesity drugs, a larger benefit will probably flow to society.
Rating:
0.0
Views:
12
Likes:
1
Library:
1
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value